SAU:4009

Middle East Healthcare Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:39 UTC

Last close

n/aSAR

Market data

  • 7.0xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed
    • Computed from the filing for 2025
  • 8.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 9.7%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -3.2%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.36Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed

Follow one riyal

lens 1 of 9
After what it costs to make
37.4%
After running the business
12.6%
After interest and tax
9.7%
After what it must reinvest
-3.2%
Kept after the dividend
-4.7%
after what it costs to make, 37.4% of sales; after running the business, 12.6% of sales; after interest and tax, 9.7% of sales; after what it must reinvest, -3.2% of sales; kept after the dividend, -4.7% of sales

The five stops

5 of 5 read
  • After what it costs to make1,160,040,00037.4%
  • After running the business390,591,24612.6%
  • After interest and tax301,880,0009.7%
  • After what it must reinvest-99,759,800-3.2%
  • Kept after the dividend-145,779,800-4.7%

Of every unit of sales, -0.05 is still there after the dividend.

Of every unit of sales, -0.05 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales3,102,630,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After what it costs to make1,160,040,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After running the business390,591,246
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After interest and tax301,880,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After what it must reinvest-99,759,800
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Kept after the dividend-145,779,800
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.